Tepnel Life Sciences plc ("the Company")

Holding in Company

The Company was informed on 3 July 2008 by AXA Investment Managers UK Limited that AXA

S.A. 25 Avenue Matignon, 75008 Paris and its group companies are interested in
14,530,450 ordinary shares in the Company ("Ordinary Shares") representing 6.31% of the
issued share capital of the Company. These shares are represented by indirect holdings held
by the following: 

For further information:

Tepnel Life Sciences plc

Ben Matzilevich, Chief Executive Officer

Michael Slater, Group Finance Director

Tel: 0161 946 2200

Capital MS&L

Mary Clark or Joanna Whineray

Tel: +44 20 7307 5330

Seymour Pierce Limited

Mark Percy

Tel: +44 20 7107 8000

Notes to Editors:

About Tepnel Life Sciences plc

Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences products and services Group with two divisions, Molecular Diagnostics and Research Products & Services. The Company has laboratories, manufacturing and operations in the USA, UK and France with over 200 employees. Tepnel provides test kits, reagents and services to two highly synergistic markets, these being Molecular Diagnostics and Biomedical Research. The Company's strategy has been to identify high growth niche opportunities within these multi-billion pound markets. Tepnel focuses on these niche operations with internally developed products, patents, expertise and know-how as well as strategic acquisitions, to develop a leadership position within these 

• News Channel